In this regard, the enzyme-linked immunosorbent assay (ELISA) test has been suggested to be a useful tool for the validation of soluble α-Klotho measurements not only in healthy individuals but also in patients (e.g., diabetes or chronic kidney disease (CKD)) [19]. The gene discussed is KL; the disease is chronic kidney disease.